Skip to main content




) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day down 0.8%. By the end of trading, Amgen fell $1.08 (-1.5%) to $71.38 on average volume. Throughout the day, 3.7 million shares of Amgen exchanged hands as compared to its average daily volume of 4.2 million shares. The stock ranged in price between $71.36-$72.19 after having opened the day at $71.87 as compared to the previous trading day's close of $72.46. Other company's within the Health Care sector that declined today were:

Ventrus Biosciences



), down 59%,

Momenta Pharmaceuticals



), down 22.4%,

K-V Pharmaceutical Company



), down 15.4%, and

TheStreet Recommends

Impax Laboratories



), down 11.6%.

  • ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!

Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. Amgen has a market cap of $55.72 billion and is part of the


industry. The company has a P/E ratio of 16.6, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are up 12.8% year to date as of the close of trading on Friday. Currently there are 10 analysts that rate Amgen a buy, one analyst rates it a sell, and 13 rate it a hold.

TheStreet Ratings rates Amgen as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, notable return on equity, attractive valuation levels and increase in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front,

Aoxing Pharmaceutical Company



), up 26.8%,




), up 20.7%,

Horizon Pharma



), up 18%, and

Alexza Pharmaceuticals



), up 16.4%, were all gainers within the health care sector with

Spectrum Pharmaceuticals



) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR



) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care